Legend Biotech (FRA:9LB) Marketable Securities : €372.4 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Legend Biotech's Marketable Securities for the quarter that ended in Mar. 2024 was €372.4 Mil.

Legend Biotech's annual Marketable Securities increased from Dec. 2021 (€171.2 Mil) to Dec. 2022 (€226.2 Mil) but then declined from Dec. 2022 (€226.2 Mil) to Dec. 2023 (€28.4 Mil).

Legend Biotech Marketable Securities Historical Data

The historical data trend for Legend Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Marketable Securities Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

68.00

41.10

171.21

226.20

28.43

Legend Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															177.53	259.89	431.36	28.43	372.42

Legend Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Legend Biotech (FRA:9LB) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Legend Biotech Marketable Securities Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech (FRA:9LB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

LEGN:USA

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Legend Biotech (FRA:9LB) Headlines

No Headlines